An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
While treadmill exercise stress testing is essential to detect cardiovascular disease, gaining clear cardiac images at peak stress level are not easy to gain using standard testing procedures. Now, however, researchers at the Ohio State University Medical Centre have designed equipment to provide high-resolution cardiac images at a critical testing stage, with results in under one hour.
Atlanta-based Velocity Medical Solutions launched VelocityAI, its new molecular imaging software, at the 2008 American Association of Physicists Medicine (AAPM) in July.
Last October the Food and Drugs Administration (FDA) added a black box warning on ultrasound (US) contrast agents used in echocardiogram imaging examinations, around 200 reports of serious allergic reactions were received. Problems included cardiac arrest as well as breathing difficulty and seizures; seven of the cases resulted in death.
The belief that iodinated contrast agents can induce nephropathy has been held for many years, even though most of the clinical literature has not been able to distinguish contrast-induced nephropathy from other causes of the condition.
The drug information system AiDKlinik developed by Dosing GmbH is a software solution for the server-based intranet for medication dosing.
The first robotised tele-ultrasound examination has been performed by participants in the European Mobile And Robotised Tele-echography (MARTE) project, in collaboration with Robosoft, specialist in the development and production of service robot systems.
Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to FDA guidelines, as a pre-marketing condition for release in the USA.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
Stefan G Ruehm, Kambiz Nael, Derek Lohan and Henrik J Michaely* describe impressive images that benefit patient treatment
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Every summer the European Society of Cardiology (ESC) holds Europe's biggest annual meeting of specialists in cardiovascular medicine, inviting and drawing in top international medical professionals. Karoline Laarmann asked Professor Kim Fox, President of the European Society of Cardiology and Consultant Cardiologist at the Royal Brompton Hospital, and professor of clinical cardiology at Imperial…
More than 4,500 cancer and radiotherapy specialists will gather in Göteborg, Sweden, this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held between the 14th and 18th September 2008 at the Göteborg Convention Centre in Göteborg.
A new study reveals that, with dual-source computed tomography (DSCT), the effective dosage for a heart examination can be significantly lowered, in comparison to conventional computed tomography (CT). The study also demonstrated that stenoses can be diagnosed with the same high accuracy as with invasive x-ray angiography.
US- researchers found that inpatients experience an average of nearly one and a half potentially harmful errors in their medication record during a hospital stay. They started the search for the causes: admission and discharging are the most dangerous situations.
Women who survive breast cancer for at least five years have a 89% chance that it will not recure. But those, who are still suffering and on endocrine treatment are likely to get arthralgia and arthritis.
The “Project Connect”, a program designed to build Public Private Partnerships to combat HIV and tuberculosis in India recently recorded a huge success:
Compact ultrasound technology provides greater diagnostic confidence within close proximity of athletes. The portable equipment from GE Healthcare is not much larger than a laptop, and delivers comparable results in terms of display quality to the high-end equipment used in hospitals.
More than 250,000 women under the age of forty are living with the disease in the US and 11,000 will be diagnosed in the next year. Even so, young women are underrepresented in many research studies and treatments, according to genomic expert Simon Chin.
The idea of measuring tissue stiffness using ultrasound is nothing new. But lately the field sets a rapid pace. “Real-time, hand-held elastography is now a commercial reality,” asserts Jonathan Ophir from the University of Texas Medical School.
The so-called 11-labeled Pittsburgh Compound B ([11C]PiB) type of positron emission tomography (PET) may be useful in a non-invasive assessment of the formation of Alzheimer's disease-related plaques, according to a study that will appear in the October 2008 issue of Archives of Neurology.
To make sure that for athletes and officials the Beijing 2008 Olympic Games will not come to a premature end, digital medical and dental imaging systems from Carestream Health, Inc. are available to diagnose and treat any health concerns.
Treadmill exercise testing is a common tool to detect of cardiovascular diseases. But clear images of the working heart are hard to obtain. Now researchers designed MRI equipment to provide high-resolution images of the heart at critical stages.
Researchers compared the Norwegian organised population based mammogram screening every second year and a physician- or self-referrals annual test in the US. Both are equally sensitive, but the recall rate for abnormal results was lower in Norway.
